바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

logo

메뉴
search

ISSN : 0376-4672

논문 상세

다음
논문 투고

61권 13호

Sclerotherapy for Oral Vascular Malformation Using Sodium Tetradecyl Sulfate: Case Series

권찬욱 (경북대학교 치과대학 구강악안면외과학교실)
김도형 (경북대학교 치과대학 구강악안면외과학 교실)
이성탁 (경북대학교 치과대학 구강악안면외과학 교실)
대한치과의사협회지 / The Journal of the Korean Dental Association, (P)0376-4672; (E)2713-7961
2023, v.61 no.13, pp.834-844
https://doi.org/10.22974/jkda.2023.61.13.001
권찬욱, 김도형, & 이성탁. (2023). . 대한치과의사협회지, 61(13), 834-844, https://doi.org/10.22974/jkda.2023.61.13.001

Abstract

Vascular malformations in the oral cavity are congenital vascular anomalies with potential functional and aesthetic im plication. Over the years, the demand for effective and minimally invasive treatments for oral vascular malformations has increased. This study presents a case series of six patients diagnosed with oral vascular malformations, who underwent sclerotherapy using sodium tetradecyl sulfate. Treatment showed satisfying results without any recurrence.

keywords
Vascular Malformation, Vascular anomalies, Hemangioma, Sclerotherapy

참고문헌

1.

1. Neville, B.W., Damm, D.D., Allen, C.M. and Chi, A.C. Oral &Maxillofacial Pathology. 4th Edition, WB Saunders, Elsevier, Missouri, (2016) 604-605. p. 504-508.

2.

2. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982 Mar;69(3):412-22. doi: 10.1097/00006534-198203000-00002.

3.

3. Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol. 2005 Jan;53(1):35-45. doi:10.1016/j.ejrad.2004.07.023.

4.

4. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions:clinical application of a new classification. J Pediatr Surg. 1983Dec;18(6):894-900. doi: 10.1016/s0022-3468(83)80043-8.

5.

5. Tyagi I, Syal R, Goyal A. Management of low-flow vascular malformations of upper aero digestive system-role of N-butyl cyanoacrylate in peroperative devascularization. Br J Oral Maxillofac Surg. 2006 Apr;44(2):152-6. doi: 10.1016/j.bjoms.2005.04.005. Epub 2005 Jun 6.

6.

6. Baurmash H, DeChiara S. A conservative approach to the management of orofacial vascular lesions in infants and children: report of cases. J Oral Maxillofac Surg. 1991 Nov;49(11):1222-5. doi: 10.1016/0278-2391(91)90422-i.

7.

7. Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases. Pediatr Surg Int. 2011 May;27(5):527-31. doi: 10.1007/s00383-010-2824-x.

8.

8. Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000 Mar;31(3):462-71.

9.

9. Donnelly LF, Adams DM, Bisset GS 3rd. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol. 2000 Mar;174(3):597-608. doi:10.2214/ajr.174.3.1740597.

10.

10. Redondo P. Malformaciones vasculares (I). Concepto, clasificación, fisiopatogenia y manifestaciones clínicas [Vascular malformations (I). Concept, classification, pathogenesis and clinical features]. Actas Dermosifiliogr. 2007 Apr;98(3):141-58. Spanish.

11.

11. George A, Mani V, Noufal A. Update on the classification of hemangioma. J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S117-20. doi: 10.4103/0973-029X.141321.

12.

12. Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis. 2010 Jul;16(5):405-18. doi:10.1111/j.1601-0825.2010.01661.x. Epub 2010 Mar 9.

13.

13. Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol. 2002May;13(5):475-82. doi: 10.1016/s1051-0443(07)61527-9.

14.

14. Jayakumar PN, Desai SV, Kovoor JM, Vasudev MK. Percutaneous embolization of mandibular hemangioma: a case report. J Oral Maxillofac Surg. 2002 Aug;60(8):945-8. doi: 10.1053/joms.2002.33869.

15.

15. Muto T, Kinehara M, Takahara M, Sato K. Therapeutic embolization of oral hemangiomas with absolute ethanol. J Oral Maxillofac Surg. 1990 Jan;48(1):85-8. doi: 10.1016/0278-2391(90)90188-8.

16.

16. Tanaka T, Morimoto Y, Takano H, Tominaga K, Kito S, Okabe S, Takahashi T, Fukuda J, Ohba T. Three-dimensional identification of hemangiomas and feeding arteries in the head and neck region using combined phase-contrast MR angiography and fast asymmetric spin-echo sequences. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Nov;100(5):609-13. doi:10.1016/j.tripleo.2005.06.009.

17.

17. BAURMASH H, MANDEL L. The nonsurgical treatment of hemangioma with Sotradecol. Oral Surg Oral Med Oral Pathol. 1963 Jul;16:777-82. doi: 10.1016/0030-4220(63)90313-x.

18.

18. Sadeghi E, Gingrass D. Oral hemangioma treated with a sclerosing agent. Report of a case. Int J Oral Maxillofac Surg. 1989Oct;18(5):262-3. doi: 10.1016/s0901-5027(89)80089-x.

19.

19. Goldman MP, Bergan JJ. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 3rd ed. St. Louis: Mosby;2001:1–6.

20.

20. Parsi K, Exner T, Low J, Ma DD, Joseph JE. In vitro effects of detergent sclerosants on antithrombotic mechanisms. Eur J Vasc Endovasc Surg. 2009 Aug;38(2):220-8. doi: 10.1016/j. ejvs.2009.03.026. Epub 2009 May 12

logo

논문 투고
OA 정책